Systemic Therapy for Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC)

This supplement is sponsored by Regeneron Pharmaceuticals, Inc. and sanofi-aventis U.S. LLC


Click to Read

Advanced cutaneous squamous cell carcinoma (CSCC) often carries a poor prognosis. 1 However, historically, pateints have lacked FDA-approved treatment options, and evidence regarding systemic treatment for advanced CSCC has been limited.

This supplement discusses:

  • CSCC incidence, including prevalence among active-duty military service members and veterans
  • Diagnosis and treatment guidelines
  • Local and advanced stage CSCC treatment options
  • Clinical trial results of a systemic therapy for advanced CSCC

Click to Read


1. Burton K, Ashack K, Khachemoune A. Cutaneous squamous cell carcinoma: A review of high-risk and metastatic disease. Am J Clin Dermatol. 2016;17(5):491-508.

LIB.20.03.0051 04/20

Next Article: